The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 06, 2024
Filed:
Dec. 08, 2022
Applicant:
Ascendis Pharma Bone Diseases A/s, Hellerup, DK;
Inventors:
Kennett Sprogøe, Holte, DK;
Felix Cleemann, Mainz, DE;
Guillaume Maitro, Mannheim, DE;
Mathias Krusch, Hirschhorn, DE;
Thomas Wegge, Heidelberg, DE;
Joachim Zettler, Heidelberg, DE;
Assignee:
ASCENDIS PHARMA BONE DISEASES A/S, Hellerup, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/29 (2006.01); A61K 47/60 (2017.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 47/54 (2017.01); A61K 47/34 (2017.01);
U.S. Cl.
CPC ...
A61K 38/29 (2013.01); A61K 9/0019 (2013.01); A61K 9/1647 (2013.01); A61K 47/54 (2017.08); A61K 47/545 (2017.08); A61K 47/60 (2017.08); A61K 47/34 (2013.01);
Abstract
The present invention relates to a controlled-release parathyroid hormone (PTH) compound in which PTH(1-34) is reversibly conjugated to a branched polyethylene glycol. The invention further relates to a pharmaceutical composition of the compound. The compound or pharmaceutical composition is useful for treatment, control, delay or prevention of a condition that can be treated, controlled, delayed or prevented with PTH.